326 related articles for article (PubMed ID: 2845932)
1. The design of peptidyldiazomethane inhibitors to distinguish between the cysteine proteinases calpain II, cathepsin L and cathepsin B.
Crawford C; Mason RW; Wikstrom P; Shaw E
Biochem J; 1988 Aug; 253(3):751-8. PubMed ID: 2845932
[TBL] [Abstract][Full Text] [Related]
2. The affinity-labelling of cathepsin S with peptidyl diazomethyl ketones. Comparison with the inhibition of cathepsin L and calpain.
Shaw E; Mohanty S; Colic A; Stoka V; Turk V
FEBS Lett; 1993 Nov; 334(3):340-2. PubMed ID: 8243643
[TBL] [Abstract][Full Text] [Related]
3. Biotin-labelled peptidyl diazomethane inhibitors derived from the substrate-like sequence of cystatin: targeting of the active site of cruzipain, the major cysteine proteinase of Trypanosoma cruzi.
Lalmanach G; Mayer R; Serveau C; Scharfstein J; Gauthier F
Biochem J; 1996 Sep; 318 ( Pt 2)(Pt 2):395-9. PubMed ID: 8809025
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effect of di- and tripeptidyl aldehydes on calpains and cathepsins.
Sasaki T; Kishi M; Saito M; Tanaka T; Higuchi N; Kominami E; Katunuma N; Murachi T
J Enzyme Inhib; 1990; 3(3):195-201. PubMed ID: 2079636
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and properties of Cbz-Phe-Arg-CHN2 (benzyloxycarbonylphenylalanylarginyldiazomethane) as a proteinase inhibitor.
Zumbrunn A; Stone S; Shaw E
Biochem J; 1988 Mar; 250(2):621-3. PubMed ID: 3355540
[TBL] [Abstract][Full Text] [Related]
6. The identification of active forms of cysteine proteinases in Kirsten-virus-transformed mouse fibroblasts by use of a specific radiolabelled inhibitor.
Mason RW; Wilcox D; Wikstrom P; Shaw EN
Biochem J; 1989 Jan; 257(1):125-9. PubMed ID: 2537618
[TBL] [Abstract][Full Text] [Related]
7. Lysosomal cysteine endopeptidases mediate interleukin 1-stimulated cartilage proteoglycan degradation.
Buttle DJ; Saklatvala J
Biochem J; 1992 Oct; 287 ( Pt 2)(Pt 2):657-61. PubMed ID: 1445226
[TBL] [Abstract][Full Text] [Related]
8. The properties of peptidyl diazoethanes and chloroethanes as protease inactivators.
Wikstrom P; Kirschke H; Stone S; Shaw E
Arch Biochem Biophys; 1989 Apr; 270(1):286-93. PubMed ID: 2930191
[TBL] [Abstract][Full Text] [Related]
9. The use of benzyloxycarbonyl[125I]iodotyrosylalanyldiazomethane as a probe for active cysteine proteinases in human tissues.
Mason RW; Bartholomew LT; Hardwick BS
Biochem J; 1989 Nov; 263(3):945-9. PubMed ID: 2597135
[TBL] [Abstract][Full Text] [Related]
10. Inactivation of calpain by peptidyl fluoromethyl ketones.
Angliker H; Anagli J; Shaw E
J Med Chem; 1992 Jan; 35(2):216-20. PubMed ID: 1732539
[TBL] [Abstract][Full Text] [Related]
11. Labelling of cysteine proteinases in purified lysosomes.
Wilcox D; Mason RW
Biochem Soc Trans; 1989 Dec; 17(6):1080-1. PubMed ID: 2628091
[No Abstract] [Full Text] [Related]
12. Cystatin C based peptidyl diazomethanes as cysteine proteinase inhibitors: influence of the peptidyl chain length.
Hall A; Abrahamson M; Grubb A; Trojnar J; Kania P; Kasprzykowska R; Kasprzykowski F
J Enzyme Inhib; 1992; 6(2):113-23. PubMed ID: 1284427
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of growth of human TE2 and C-33A cells by the cell-permeant calpain inhibitor benzyloxycarbonyl-Leu-Leu-Tyr diazomethyl ketone.
Mellgren RL; Shaw E; Mericle MT
Exp Cell Res; 1994 Nov; 215(1):164-71. PubMed ID: 7957664
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological activity of a series of potent fluoromethyl ketone inhibitors of recombinant human calpain I.
Chatterjee S; Ator MA; Bozyczko-Coyne D; Josef K; Wells G; Tripathy R; Iqbal M; Bihovsky R; Senadhi SE; Mallya S; O'Kane TM; McKenna BA; Siman R; Mallamo JP
J Med Chem; 1997 Nov; 40(23):3820-8. PubMed ID: 9371247
[TBL] [Abstract][Full Text] [Related]
15. Cathepsin B and L activities in isolated osteoclasts.
Rifkin BR; Vernillo AT; Kleckner AP; Auszmann JM; Rosenberg LR; Zimmerman M
Biochem Biophys Res Commun; 1991 Aug; 179(1):63-9. PubMed ID: 1883385
[TBL] [Abstract][Full Text] [Related]
16. Rapid interaction of cathepsin L by Z-Phe-PheCHN12 and Z-Phe-AlaCHN2.
Kirschke H; Shaw E
Biochem Biophys Res Commun; 1981 Jul; 101(2):454-8. PubMed ID: 7306089
[No Abstract] [Full Text] [Related]
17. Rat mammary gland in culture secretes a stable high molecular weight form of cathepsin L.
Recklies AD; Mort JS
Biochem Biophys Res Commun; 1985 Aug; 131(1):402-7. PubMed ID: 4038303
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of cysteine proteinase activity by Z-Phe-Phe-diazomethane and of aspartic proteinase activity by pepstatin in different organs from some animals and isolated cells from rat liver.
Riemann S; Kirschke H; Wiederanders B; Brouwer A; Shaw E; Bohley P
Acta Biol Med Ger; 1982; 41(1):83-8. PubMed ID: 7051705
[TBL] [Abstract][Full Text] [Related]
19. Isolation of a Chinese hamster ovary cell clone possessing decreased mu-calpain content and a reduced proliferative growth rate.
Mellgren RL; Lu Q; Zhang W; Lakkis M; Shaw E; Mericle MT
J Biol Chem; 1996 Jun; 271(26):15568-74. PubMed ID: 8663205
[TBL] [Abstract][Full Text] [Related]
20. L-trans-Epoxysuccinyl-leucylamido(4-guanidino)butane (E-64) and its analogues as inhibitors of cysteine proteinases including cathepsins B, H and L.
Barrett AJ; Kembhavi AA; Brown MA; Kirschke H; Knight CG; Tamai M; Hanada K
Biochem J; 1982 Jan; 201(1):189-98. PubMed ID: 7044372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
